BC-PIV SARS-CoV-2 vaccine (BioComo/MediciNova/Mie University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBC-PIV SARS-CoV-2 vaccine (BioComo/MediciNova/Mie University)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMie UniversityBioComo Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedicinova Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A